328 related articles for article (PubMed ID: 23162750)
1. High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes.
Martinet L; Le Guellec S; Filleron T; Lamant L; Meyer N; Rochaix P; Garrido I; Girard JP
Oncoimmunology; 2012 Sep; 1(6):829-839. PubMed ID: 23162750
[TBL] [Abstract][Full Text] [Related]
2. The density and type of MECA-79-positive high endothelial venules correlate with lymphocytic infiltration and tumour regression in primary cutaneous melanoma.
Avram G; Sánchez-Sendra B; Martín JM; Terrádez L; Ramos D; Monteagudo C
Histopathology; 2013 Dec; 63(6):852-61. PubMed ID: 24102908
[TBL] [Abstract][Full Text] [Related]
3. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer.
Martinet L; Garrido I; Filleron T; Le Guellec S; Bellard E; Fournie JJ; Rochaix P; Girard JP
Cancer Res; 2011 Sep; 71(17):5678-87. PubMed ID: 21846823
[TBL] [Abstract][Full Text] [Related]
4. High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin β-producing dendritic cells in human breast cancer.
Martinet L; Filleron T; Le Guellec S; Rochaix P; Garrido I; Girard JP
J Immunol; 2013 Aug; 191(4):2001-8. PubMed ID: 23825314
[TBL] [Abstract][Full Text] [Related]
5. High endothelial venules in intracranial germinomas: Implications for lymphocytes infiltration.
Chen H; Li G; Cui Y; Zhang Q; Li B; Liu X
Cancer Med; 2023 Mar; 12(5):5450-5460. PubMed ID: 36259639
[TBL] [Abstract][Full Text] [Related]
6. Correlation with lymphocyte infiltration, but lack of prognostic significance of MECA-79-positive high endothelial venules in primary malignant melanoma.
Sebestyén T; Mohos A; Liszkay G; Somlai B; Gaudi I; Ladányi A
Melanoma Res; 2018 Aug; 28(4):304-310. PubMed ID: 29683859
[TBL] [Abstract][Full Text] [Related]
7. High endothelial venules (HEVs) in immunity, inflammation and cancer.
Blanchard L; Girard JP
Angiogenesis; 2021 Nov; 24(4):719-753. PubMed ID: 33956259
[TBL] [Abstract][Full Text] [Related]
8. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor.
Ladányi A; Kiss J; Somlai B; Gilde K; Fejos Z; Mohos A; Gaudi I; Tímár J
Cancer Immunol Immunother; 2007 Sep; 56(9):1459-69. PubMed ID: 17279413
[TBL] [Abstract][Full Text] [Related]
9. High Endothelial Venule with Concomitant High CD8+ Tumor-Infiltrating Lymphocytes Is Associated with a Favorable Prognosis in Resected Gastric Cancer.
Hong SA; Hwang HW; Kim MK; Lee TJ; Yim K; Won HS; Sun S; Kim EY; Ko YH
J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32823631
[TBL] [Abstract][Full Text] [Related]
10. Density of high endothelial venules and PDL-1 expression: relationship with tumor-infiltrating lymphocytes in primary cutaneous melanomas.
Stolfo JB; Motta ACD
An Acad Bras Cienc; 2024; 96(1):e20230441. PubMed ID: 38511744
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy.
Asrir A; Tardiveau C; Coudert J; Laffont R; Blanchard L; Bellard E; Veerman K; Bettini S; Lafouresse F; Vina E; Tarroux D; Roy S; Girault I; Molinaro I; Martins F; Scoazec JY; Ortega N; Robert C; Girard JP
Cancer Cell; 2022 Mar; 40(3):318-334.e9. PubMed ID: 35120598
[TBL] [Abstract][Full Text] [Related]
12. Binding of lymphoid chemokines to collagen IV that accumulates in the basal lamina of high endothelial venules: its implications in lymphocyte trafficking.
Yang BG; Tanaka T; Jang MH; Bai Z; Hayasaka H; Miyasaka M
J Immunol; 2007 Oct; 179(7):4376-82. PubMed ID: 17878332
[TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint ligands expressed on mature high endothelial venules predict poor prognosis of NSCLC: have a relationship with CD8
Luo J; Shi X; Liu Y; Wang J; Wang H; Yang X; Sun Q; Hui Z; Wei F; Ren X; Zhao H
Front Immunol; 2024; 15():1302761. PubMed ID: 38390332
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte recruitment via high endothelial venules in lymphoid stroma of Warthin's tumour.
Ohya A; Kobayashi M; Sakai Y; Kawashima H; Kageyama S; Nakayama J
Pathology; 2013 Feb; 45(2):150-4. PubMed ID: 23250041
[TBL] [Abstract][Full Text] [Related]
15. High endothelial venule-like vessels and lymphocyte recruitment in testicular seminoma.
Sakai Y; Hoshino H; Kitazawa R; Kobayashi M
Andrology; 2014 Mar; 2(2):282-9. PubMed ID: 24519996
[TBL] [Abstract][Full Text] [Related]
16. High endothelial venules are rare in colorectal cancers but accumulate in extra-tumoral areas with disease progression.
Bento DC; Jones E; Junaid S; Tull J; Williams GT; Godkin A; Ager A; Gallimore A
Oncoimmunology; 2015 Mar; 4(3):e974374. PubMed ID: 25949892
[TBL] [Abstract][Full Text] [Related]
17. 4-nitroquinoline 1-oxide-induced oral epithelial lesions exhibit time- and stage-dependent changes in the tumor immune microenvironment.
Sellæg K; Schwienbacher R; Kranz M; Aamodt AE; Wirsing AM; Berge G; Hadler-Olsen E; Magnussen SN
Front Oncol; 2024; 14():1343839. PubMed ID: 38812785
[TBL] [Abstract][Full Text] [Related]
18. High endothelial venules associated with T cell subsets in the inflamed gut of newly diagnosed inflammatory bowel disease patients.
Horjus Talabur Horje CS; Smids C; Meijer JW; Groenen MJ; Rijnders MK; van Lochem EG; Wahab PJ
Clin Exp Immunol; 2017 Apr; 188(1):163-173. PubMed ID: 28033681
[TBL] [Abstract][Full Text] [Related]
19. High endothelial venules are present in pharyngeal and laryngeal carcinomas and they are associated with better prognosis.
Karpathiou G; Dumollard JM; Gavid M; Casteillo F; Vieville M; Prades JM; Froudarakis M; Peoc'h M
Pathol Res Pract; 2021 Apr; 220():153392. PubMed ID: 33647862
[TBL] [Abstract][Full Text] [Related]
20. HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy.
Bravo AI; Aris M; Panouillot M; Porto M; Dieu-Nosjean MC; Teillaud JL; Barrio MM; Mordoh J
Front Immunol; 2023; 14():1231734. PubMed ID: 37691949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
